We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?
BusinessNews

FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?

BarbaraDuck
BarbaraDuck
Share
2 Min Read
SHARE

Ok so a little humor as you are only supposed to have this sleeping aid if you already have some sleep under your belt.  It’s a lower dose so that one does not get up and take another full dose is what I get from this one.

Ok so a little humor as you are only supposed to have this sleeping aid if you already have some sleep under your belt.  It’s a lower dose so that one does not get up and take another full dose is what I get from this one. image

The middle of the night is kind of funny actually as it’s just a lower dose pill, what they not stop at to market!  I would think one could take a lower dose if their issues I sleeping were not as drastic, right?  Also the way the article reads it assumes that you have already taken one full strength pill so this is safer than a double dose.  I’m not a bit sleeping pill person and have taken a few in my life but I hate the sleeping pill hang over so when I have those occasional nights, the half glass of wine for me still works well.  BD 

Federal health regulators say they have approved the first insomnia pill designed for people who wake up in the middle of the night and have trouble getting back to sleep.

Transcept Pharmaceuticals’ Intermezzo pill is a lower dose of the key ingredient in Ambien, the popular sleep medication first approved in 1992. FDA officials say the new pill offers a safer option than taking a second dose of zolpidem tartrate, the ingredient in Sanofi’s Ambien, to get back to sleep.

“With this lower dose there is less risk of a person having too much drug in the body upon waking, which can cause dangerous drowsiness and impair driving,” said Dr. Robert Temple, director for clinical science in FDA’s drug center.

 

More Read

Patient Satisfaction Strongly Tied to Corporate Culture
Ideal Medtech Products
Doctors: Beware the Doc Fix
Renowned Dallas Hospital Out of Medicare Compliance
5 Collection Strategies That Won’t Ruin Your Relationship with Patients

TAGGED:FDAIntermezzopharmaceuticalssleeping pill
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Clinical-trial operations editorial illustration combining healthcare and technology: country-specif
Clinical Study Operations Across Eastern European Research Markets
Health
October 31, 2026
Flat editorial illustration: A health-editorial scene of a first pain-management visit, bringing together attentive consultation,
What to Expect at Your First Pain Management Appointment
Therapies Wellness
October 29, 2026
Flat editorial illustration: The core relationship is medication-only coverage versus coverage for a supervised clinical program.
Medical Weight Loss as a Workplace Benefit: The Questions I Would Want Asked
Weight Loss Wellness
October 29, 2026
Common Questions About Tirzepatide and Medical Monitoring -- AI-generated illustration
Common Questions About Tirzepatide and Medical Monitoring
Health
October 26, 2026

You Might also Like

Image
eHealthNews

Proposal to Restrict Online Prescribing Would Hinder Telemedicine

May 15, 2012
Community Pharmacy Accreditation
BusinessFinanceHealth ReformPolicy & LawPublic Health

URAC Expands Pharmacy Accreditation Options: Community Pharmacy

May 17, 2014

4 Good Apps for Flu Season

December 8, 2011

Five Ways to Rock Healthcare Marketing in 2015

January 27, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?